vs
Side-by-side financial comparison of ROGERS CORP (ROG) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $200.5M, roughly 1.0× ROGERS CORP). ROGERS CORP runs the higher net margin — 2.2% vs 1.1%, a 1.1% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs 4.9%). ROGERS CORP produced more free cash flow last quarter ($1.1M vs $-26.8M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -3.3%).
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
ROG vs VREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $200.5M | $209.6M |
| Net Profit | $4.5M | $2.3M |
| Gross Margin | 32.2% | 33.3% |
| Operating Margin | — | 7.3% |
| Net Margin | 2.2% | 1.1% |
| Revenue YoY | 5.2% | 4.9% |
| Net Profit YoY | 421.4% | 866.7% |
| EPS (diluted) | $0.25 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $200.5M | $209.6M | ||
| Q4 25 | $201.5M | $228.9M | ||
| Q3 25 | $216.0M | $203.0M | ||
| Q2 25 | $202.8M | $212.9M | ||
| Q1 25 | $190.5M | $199.8M | ||
| Q4 24 | $192.2M | — | ||
| Q3 24 | $210.3M | $205.7M | ||
| Q2 24 | $214.2M | $209.1M |
| Q1 26 | $4.5M | $2.3M | ||
| Q4 25 | $4.6M | $12.2M | ||
| Q3 25 | $8.6M | $-89.1M | ||
| Q2 25 | $-73.6M | $6.9M | ||
| Q1 25 | $-1.4M | $-300.0K | ||
| Q4 24 | $-500.0K | — | ||
| Q3 24 | $10.7M | $-51.1M | ||
| Q2 24 | $8.1M | $1.4M |
| Q1 26 | 32.2% | 33.3% | ||
| Q4 25 | 31.5% | 34.0% | ||
| Q3 25 | 33.5% | 33.3% | ||
| Q2 25 | 31.6% | 36.0% | ||
| Q1 25 | 29.9% | 34.3% | ||
| Q4 24 | 32.1% | — | ||
| Q3 24 | 35.2% | 32.6% | ||
| Q2 24 | 34.1% | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 3.5% | 8.6% | ||
| Q3 25 | 7.3% | -39.8% | ||
| Q2 25 | -33.3% | 10.4% | ||
| Q1 25 | -0.2% | 5.6% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | 6.9% | 5.3% | ||
| Q2 24 | 5.3% | 4.4% |
| Q1 26 | 2.2% | 1.1% | ||
| Q4 25 | 2.3% | 5.3% | ||
| Q3 25 | 4.0% | -43.9% | ||
| Q2 25 | -36.3% | 3.2% | ||
| Q1 25 | -0.7% | -0.2% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 5.1% | -24.8% | ||
| Q2 24 | 3.8% | 0.7% |
| Q1 26 | $0.25 | $0.05 | ||
| Q4 25 | $0.20 | $0.29 | ||
| Q3 25 | $0.48 | $-2.15 | ||
| Q2 25 | $-4.00 | $0.17 | ||
| Q1 25 | $-0.08 | $-0.01 | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.58 | $-1.25 | ||
| Q2 24 | $0.44 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.8M | $125.6M |
| Total DebtLower is stronger | — | $367.6M |
| Stockholders' EquityBook value | $1.2B | $476.9M |
| Total Assets | $1.4B | $1.1B |
| Debt / EquityLower = less leverage | — | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $195.8M | $125.6M | ||
| Q4 25 | $197.0M | $155.1M | ||
| Q3 25 | $167.8M | $152.6M | ||
| Q2 25 | $157.2M | $223.0M | ||
| Q1 25 | $175.6M | $212.6M | ||
| Q4 24 | $159.8M | — | ||
| Q3 24 | $146.4M | $200.5M | ||
| Q2 24 | $119.9M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | $1.2B | $476.9M | ||
| Q4 25 | $1.2B | $472.6M | ||
| Q3 25 | $1.2B | $455.3M | ||
| Q2 25 | $1.2B | $549.7M | ||
| Q1 25 | $1.3B | $540.2M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $529.1M | ||
| Q2 24 | $1.3B | $581.2M |
| Q1 26 | $1.4B | $1.1B | ||
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.8M | $-16.1M |
| Free Cash FlowOCF − Capex | $1.1M | $-26.8M |
| FCF MarginFCF / Revenue | 0.5% | -12.8% |
| Capex IntensityCapex / Revenue | 2.3% | 5.1% |
| Cash ConversionOCF / Net Profit | 1.29× | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | $70.1M | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $5.8M | $-16.1M | ||
| Q4 25 | $46.9M | $7.9M | ||
| Q3 25 | $28.9M | $7.7M | ||
| Q2 25 | $13.7M | $16.6M | ||
| Q1 25 | $11.7M | $9.5M | ||
| Q4 24 | $33.7M | — | ||
| Q3 24 | $42.4M | $25.9M | ||
| Q2 24 | $22.9M | $8.0M |
| Q1 26 | $1.1M | $-26.8M | ||
| Q4 25 | $42.2M | $2.3M | ||
| Q3 25 | $21.2M | $1.4M | ||
| Q2 25 | $5.6M | $9.8M | ||
| Q1 25 | $2.1M | $5.3M | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | $25.2M | $19.9M | ||
| Q2 24 | $8.8M | $3.3M |
| Q1 26 | 0.5% | -12.8% | ||
| Q4 25 | 20.9% | 1.0% | ||
| Q3 25 | 9.8% | 0.7% | ||
| Q2 25 | 2.8% | 4.6% | ||
| Q1 25 | 1.1% | 2.7% | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 12.0% | 9.7% | ||
| Q2 24 | 4.1% | 1.6% |
| Q1 26 | 2.3% | 5.1% | ||
| Q4 25 | 2.3% | 2.4% | ||
| Q3 25 | 3.6% | 3.1% | ||
| Q2 25 | 4.0% | 3.2% | ||
| Q1 25 | 5.0% | 2.1% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 8.2% | 2.9% | ||
| Q2 24 | 6.6% | 2.2% |
| Q1 26 | 1.29× | -7.00× | ||
| Q4 25 | 10.20× | 0.65× | ||
| Q3 25 | 3.36× | — | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.96× | — | ||
| Q2 24 | 2.83× | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ROG
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
